Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of UCP1 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
More info about UCP1 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB6905 |
| Product name: | UCP1 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of UCP1. |
| Gene id: | 7350 |
| Gene name: | UCP1 |
| Gene alias: | SLC25A7|UCP |
| Gene description: | uncoupling protein 1 (mitochondrial, proton carrier) |
| Immunogen: | A synthetic peptide corresponding to human UCP1. |
| Immunogen sequence/protein sequence: | C-EQLKRELSKSRQ |
| Protein accession: | NP_068605.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:128000) Western Blot (0.1-1 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | UCP1 polyclonal antibody (Cat # PAB6905) (1 ug/mL) staining of human adipose lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity.Ishigaki Y, Katagiri H, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Gao J, Ishihara H, Shimosegawa T, Sakoda H, Asano T, Oka Y. Diabetes. 2005 Feb;54(2):322-32. |